menu
    • menu

    Company profile for Acerta Pharma

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Acerta Pharma serves as AstraZeneca’s “Hematologic Oncology Center of Excellence”. As such, it has the responsibility of developing both internally discovered compounds as well as AstraZeneca sourced compounds for hematological malignancies. The company began operations in 2013 with the vision of combining cutting edge science, unique covalent technology, and an experienced, dedicated team in order to deliver novel targe...
    Acerta Pharma serves as AstraZeneca’s “Hematologic Oncology Center of Excellence”. As such, it has the responsibility of developing both internally discovered compounds as well as AstraZeneca sourced compounds for hematological malignancies. The company began operations in 2013 with the vision of combining cutting edge science, unique covalent technology, and an experienced, dedicated team in order to deliver novel targeted therapies for patients with cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Acerta PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    121 Oyster Point Blvd. South San Francisco, CA 94080
    Telephone
    Telephone
    650-591-2800
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.acerta-pharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ascentage and Acerta partner to evaluate Bcl-2 and BTK combination
    Ascentage and Acerta partner to evaluate Bcl-2 and BTK combination

    22 Jun 2020

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/ascentage-acerta-evaluate-inhibitors-combination/

    CLINICALTRIALSARENA
    22 Jun 2020
    Share Share
    AstraZeneca's Calquence treads on Imbruvica's turf with second phase 3 CLL win
    AstraZeneca's Calquence treads on Imbruvica's turf with second phase 3 CLL win

    07 Jun 2019

    // Carly Helfand FIERCE PHARMA

    https://www.fiercepharma.com/pharma/astrazeneca-s-calquence-treads-imbruvica-s-turf-second-ph3-cll-win

    Carly Helfand FIERCE PHARMA
    07 Jun 2019
    Share Share
    Forty Seven Inc. and Acerta Enter Collaboration
    Forty Seven Inc. and Acerta Enter Collaboration

    10 May 2019

    // GLOBE NEWSWIRE

    https://www.globenewswire.com/news-release/2019/05/10/1821791/0/en/Forty-Seven-Inc-and-Acerta-Enter-Collaboration-to-Evaluate-Novel-Immuno-Oncology-Triple-Combination-in-Diffuse-Large-B-cell-Lymphoma.html

    GLOBE NEWSWIRE
    10 May 2019
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search